SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novo Nordisk A/S: Switching to Once-Daily Victoza(R) (Liraglutide [rDNA Origin] Injection) from Exenatide Further Improves Blood Sugar Control in Patients with Type 2 Diabetes